Cargando…
Correction: Inflammatory serum factors from aortic valve stenosis patients modulate sex differences in valvular myofibroblast activation and osteoblast-like differentiation
Correction for ‘Inflammatory serum factors from aortic valve stenosis patients modulate sex differences in valvular myofibroblast activation and osteoblast-like differentiation’ by Brandon J. Vogt et al., Biomater. Sci., 2022, https://doi.org/10.1039/d2bm00844k.
Autores principales: | Vogt, Brandon J., Anseth, Kristi S., Aguado, Brian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641928/ https://www.ncbi.nlm.nih.gov/pubmed/36281803 http://dx.doi.org/10.1039/d2bm90082c |
Ejemplares similares
-
Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells
por: Cushing, Melinda C., et al.
Publicado: (2008) -
Transcatheter aortic valve replacements alter circulating serum factors to mediate myofibroblast deactivation
por: Aguado, Brian A., et al.
Publicado: (2019) -
Redirecting Valvular Myofibroblasts into Dormant Fibroblasts through Light-mediated Reduction in Substrate Modulus
por: Wang, Huan, et al.
Publicado: (2012) -
Network modeling predicts personalized gene expression and drug responses in valve myofibroblasts cultured with patient sera
por: Rogers, Jesse D., et al.
Publicado: (2022) -
The Impact of Transcatheter Aortic Valve Implantation (TAVI) on Serum Apelin Levels in Patients with Aortic Valvular Stenosis
por: Kucukosmanoglu, Mehmet, et al.
Publicado: (2021)